Mohamed ElTanbouly

Mohamed ElTanbouly

Auto-generated profile, based on publicly available information

Mohamed ElTanbouly

Laboratory of Molecular Immunology, The Rockefeller University 1 , New York, NY

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2020 in Science
Verified
Journal Article
Closed access
PDF file
MEMohamed A. ElTanbouly
Mohamed A. ElTanbouly
YZYanding Zhao
Yanding Zhao
ENElizabeth Nowak
Elizabeth Nowak
JLJiannan Li
Jiannan Li
ESEvelien Schaafsma
Evelien Schaafsma
RNRandolph Noelle
Randolph Noelle
A VISTA on naïve T cell fate: T cell quiescence and tolerance restrain the immune system from becoming overactive and attacking healthy tissue. Negative checkpoint regulators normally limit T cell responses to help safeguard against conditions such as autoimmunity. ElTanbouly et al. report that the checkpoint regulator VISTA (V-type immunoglobulin domain-containing suppressor of T cell activation) restricts early stages of T cell activation by shaping the inherent heterogeneity of the naïve CD4 + T cell compartment to one that is more uniformly quiescent and silent (see the Perspective by Brown and Rudensky). Therapeutic targeting of VISTA using an agonistic antibody in mice curbed the development of graft-versus-host disease and promoted the death of naïve T cells abnormally activated by self-antigen. VISTA thus represents a distinctive immunoregulatory molecule that controls naïve T cell function by maintaining quiescence and peripheral tolerance. Science , this issue p. eaay0524 ; see also p. 247

1 April 2019 in Seminars in Immunology
Verified
Journal Article
Closed access
MEMohamed A. ElTanbouly
Mohamed A. ElTanbouly
WCWalburga Croteau
Walburga Croteau
RNRandolph Noelle
Randolph Noelle
JLJ. Louise Lines
J. Louise Lines

13 January 2020 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
MEM A ElTanbouly
M A ElTanbouly
ESE. Schaafsma
E. Schaafsma
RNRandolph Noelle
Randolph Noelle
JLJ. L. Lines
J. L. Lines
Summary: The immune response is governed by a highly complex set of interactions among cells and mediators. T cells may be rendered dysfunctional by the presence of high levels of antigen in the absence of co-stimulation while myeloid cells may be programmed towards an immunosuppressive state that promotes cancer growth and metastasis while deterring tumor immunity. In addition, inhibitory programs driven by immune checkpoint regulators dampen anti-tumor immunity. The ideal cancer immunotherapy treatment will improve both cross-priming in the tumor microenvironment and relieve suppression by the inhibitory checkpoints. Recently, blockade of programmed cell death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) has elicited impressive results, but not in all patients, so additional targets are under investigation. V-set immunoglobulin domain suppressor of T cell activation (VISTA) is a novel immunoregulatory receptor that is broadly expressed on cells of the myeloid and lymphoid lineages, and is frequently implicated as a poor prognostic indicator in multiple cancers. Importantly, antibody targeting of VISTA uniquely engages both innate and adaptive immunity. This, combined with the expression of VISTA and its non-redundant activities compared to other immune checkpoint regulators, qualifies VISTA to be a promising target for improving cancer immunotherapy.

9 June 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CVCharlotte Viant
Charlotte Viant
TWTobias Wirthmiller
Tobias Wirthmiller
MEMohamed A. ElTanbouly
Mohamed A. ElTanbouly
SCSpencer T. Chen
Spencer T. Chen
EKErvin E. Kara
Ervin E. Kara
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Memory B cells comprise a heterogenous group of cells that differ in origin and phenotype. During the early phases of the immune response, activated B cells can differentiate into IgM-expressing memory cells, short-lived plasma cells, or seed germinal centers (GCs). The memory compartment is subsequently enriched by B cells that have been through several rounds of division and selection in the GC. Here, we report on the use of an unbiased lineage-tracking approach to explore the origins and properties of memory B cell subsets in mice with an intact immune system. We find that activated B cells continue to differentiate into memory B cells throughout the immune response. When defined on the basis of their origins, the memory B cells originating from activated B cells or GCs differ in isotype and overall gene expression, somatic hypermutation, and their affinity for antigen.

5 March 2020 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
RBRajan Bhandari
Rajan Bhandari
MBMichael S. Ball
Michael S. Ball
VMViktor Martyanov
Viktor Martyanov
DPDillon Popovich
Dillon Popovich
ESEvelien Schaafsma
Evelien Schaafsma
PPPatricia A. Pioli
Patricia A. Pioli

24 January 2025 in Science
Verified
Journal Article
Open access
AMAndrew J. MacLean
Andrew J. MacLean
LDLachlan Paul Deimel
Lachlan Paul Deimel
PZPengcheng Zhou
Pengcheng Zhou
MEMohamed A. ElTanbouly
Mohamed A. ElTanbouly
JMJulia Merkenschlager
Julia Merkenschlager
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Increased antibody affinity over time after vaccination, known as affinity maturation, is a prototypical feature of immune responses. Recent studies have shown that a diverse collection of B cells, producing antibodies with a wide spectrum of different affinities, is selected into the plasma cell (PC) pathway. How affinity-permissive selection enables PC affinity maturation remains unknown. We found that PC precursors (prePCs) expressing high-affinity antibodies received higher levels of T follicular helper cell (T FH cell)–derived help and divided at higher rates compared with their lower-affinity counterparts once they left the germinal center. Our findings indicate that differential cell division by selected prePCs accounts for how diverse precursors develop into a PC compartment that mediates serological affinity maturation.